Appili Therapeutics Inc

Research Appili Therapeutics Inc (APLI) on Bullrun: market cap CAD 1.93M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAPLI
• ExchangeTO
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCAD
• Market capCAD 1.93M
• Financial periodQ4 2025
• RevenueCAD 114.98K
• Net income-CAD 949.50K
• Free cash flow-CAD 279.84K

Valuation Snapshot

latest market cap is CAD 1.93M.

About Appili Therapeutics Inc

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis;

Frequently asked questions

What is Appili Therapeutics Inc's market cap?

Appili Therapeutics Inc's market capitalization is CAD 1.93M.

What does Appili Therapeutics Inc do?

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.